Gehrke B J, Harrod S B, Cass W A, Bardo M T
Department of Psychology, University of Kentucky, Lexington, KY 40506, USA.
Psychopharmacology (Berl). 2003 Mar;166(3):249-57. doi: 10.1007/s00213-002-1318-5. Epub 2003 Feb 13.
Methamphetamine has been shown to produce neurotoxicity demonstrated by depletions of dopamine and serotonin in the striatum and nucleus accumbens.
The current study examined the effects of neurotoxic doses of methamphetamine on the rewarding effect of subsequent administration of methamphetamine assessed by the conditioned place preference (CPP) procedure.
Male and female rats were treated with a neurotoxic regimen of methamphetamine (4 x 10 mg/kg, s.c., once every 2 h) or saline, and concentrations of dopamine, 3,4-dihydroxyphenylacetic acid, serotonin, and 5-hydroxyindoleacetic acid were measured 15 days later in the striatum, nucleus accumbens, and prefrontal cortex (PFC). In another experiment, male rats were given methamphetamine neurotoxic treatment or saline and were then conditioned 7 days later with methamphetamine (0.1, 0.3, or 1.0 mg/kg, s.c.) or saline using a four-trial CPP procedure. Locomotor activity was also measured during the conditioning sessions to investigate whether or not the neurotoxic methamphetamine treatment altered locomotor activity following a subsequent methamphetamine challenge.
Males and females did not differ significantly in the amount of neurochemical depletion produced by methamphetamine in any brain region. Collapsed across sex, dopamine was significantly depleted in nucleus accumbens (25%) and striatum (51%); serotonin was significantly depleted in nucleus accumbens (35%), striatum (34%) and PFC (33%). The methamphetamine challenge dose dependently increased locomotor activity, but the increase was not affected by treatment with neurotoxic doses of methamphetamine. In contrast, treatment with neurotoxic doses of methamphetamine enhanced CPP at the intermediate conditioning dose (0.3 mg/kg).
These results indicate that the rewarding effect of methamphetamine is enhanced by prior treatment with neurotoxic doses of methamphetamine, suggesting either a compensatory hyperfunctioning of spared dopamine neurons or a loss of inhibitory control from serotonergic input.
甲基苯丙胺已被证明会产生神经毒性,表现为纹状体和伏隔核中多巴胺和5-羟色胺的耗竭。
本研究通过条件性位置偏爱(CPP)程序,检测神经毒性剂量的甲基苯丙胺对随后给予甲基苯丙胺的奖赏效应的影响。
对雄性和雌性大鼠给予甲基苯丙胺神经毒性方案(4×10mg/kg,皮下注射,每2小时一次)或生理盐水,15天后测量纹状体、伏隔核和前额叶皮质(PFC)中多巴胺、3,4-二羟基苯乙酸、5-羟色胺和5-羟吲哚乙酸的浓度。在另一项实验中,对雄性大鼠进行甲基苯丙胺神经毒性处理或给予生理盐水,7天后使用四试验CPP程序用甲基苯丙胺(0.1、0.3或1.0mg/kg,皮下注射)或生理盐水进行条件训练。在条件训练期间还测量了运动活性,以研究神经毒性甲基苯丙胺处理是否会改变随后甲基苯丙胺激发后的运动活性。
甲基苯丙胺在任何脑区产生的神经化学物质耗竭量在雄性和雌性之间无显著差异。综合性别来看,伏隔核(25%)和纹状体(51%)中的多巴胺显著耗竭;伏隔核(35%)、纹状体(34%)和前额叶皮质(33%)中的5-羟色胺显著耗竭。甲基苯丙胺激发剂量依赖性地增加运动活性,但这种增加不受神经毒性剂量甲基苯丙胺处理的影响。相比之下,神经毒性剂量的甲基苯丙胺处理在中间条件训练剂量(0.3mg/kg)时增强了CPP。
这些结果表明,神经毒性剂量的甲基苯丙胺预处理可增强甲基苯丙胺的奖赏效应,提示要么是剩余多巴胺神经元的代偿性功能亢进,要么是5-羟色胺能输入的抑制性控制丧失。